Amplyx Pharmaceuticals (Series B, Series C, Series C Extension)
Funding Details
- Awarder
- Inbox
- Date Award
- November 11, 2015
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $53,000,000
Company Info
- Company Description
- Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
- Market
- Antifungal agents for life-threatening fungal infections
- Location
- San Diego, California, USA
- Coinvestors
- BioMed Ventures, RiverVest Venture Partners, 3x5 Partners, Arix Bioscience, Lundbeckfond Ventures, Pappas Ventures, Sofinnova Ventures, Adage Capital Management, New Enterprise Associates, Pfizer Venture Investments, Pappas Capital